XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Equity Incentive Plans (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Schedule of Stock Option Activity | A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the nine months ended September 30, 2022, are presented in the table below: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding, December 31, 2021 |  |  | 158,174 |  |  | $ | 10.99 |  |  |  | 7.60 |  |  | $ | - |
Granted |  |  | 53,960 |  |  | $ | 2.90 |  |  |  | 9.50 |  |  | $ | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited |  |  | (15,235 | ) |  | $ | 8.58 |  |  |  | 9.30 |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Outstanding, September 30, 2022 |  |  | 196,899 |  |  | $ | 8.95 |  |  |  | 7.90 |  |  | $ | - |
Exercisable, September 30, 2022 |  |  | 149,719 |  |  | $ | 9.92 |  |  |  | 7.50 |  |  | $ | - |
Summary of Non-vested Non-qualified Stock Option Activity | A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the nine months ended September 30, 2022, are presented in the table below: Summary of Non-vested Non-qualified Stock Option Activity
﻿ |  | Number of Options |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |  |  | Grant-Date Fair Value |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Nonvested, December 31, 2021 |  |  | 41,846 |  |  | $ | 7.65 |  |  | $ | - |  |  | $ | 320,122 |
Granted |  |  | 53,960 |  |  | $ | 2.86 |  |  | $ | - |  |  | $ | 153,054 |
Vested |  |  | (36,960 | ) |  | $ | 2.68 |  |  | $ | - |  |  | $ | (97,811 | )
Forfeited |  |  | (11,667 | ) |  | $ | 9.01 |  |  | $ | - |  |  | $ | (105,120 | )
Expired |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Nonvested, September 30, 2022 |  |  | 47,179 |  |  | $ | 5.73 |  |  | $ | - |  |  | $ | 270,245 |
Schedule of Restricted Stock Units Activity | Schedule of Restricted Stock Units Activity
﻿ |  | Number of Units |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2021 |  |  | - |  |  | $ | - |  |  | $ | - |
Granted |  |  | 6,734 |  |  | $ | 7.42 |  |  | $ | - |
Vested and settled with share issuance |  |  | (3,367 | ) |  | $ | 7.42 |  |  | $ | - |
Forfeited/canceled |  |  | - |  |  | $ | - |  |  | $ | - |
Outstanding, September 30, 2022 |  |  | 3,367 |  |  | $ | 7.42 |  |  | $ | - |
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Schedule of Stock Option Activity | A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine months ended September 30, 2022, are presented in the table below: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value ($000) |
Outstanding, December 31, 2021 |  |  | 50,872 |  |  | $ | 10.02 |  |  |  | 6.6 |  |  | $ | - |
Granted |  |  | 6,250 |  |  | $ | 4.80 |  |  |  | 9.3 |  |  | $ | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited/Cancelled |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Outstanding, September 30, 2022 |  |  | 57,122 |  |  | $ | 9.44 |  |  |  | 6.2 |  |  | $ | - |
Exerciseable, September 30, 2022 |  |  | 57,122 |  |  | $ | 9.44 |  |  |  | 6.2 |  |  | $ | - |
Summary of Non-vested Non-qualified Stock Option Activity | A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the nine months ended September 30, 2022, are presented in the table below: Summary of Non-vested Non-qualified Stock Option Activity
﻿ |  | Number of Options |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |  |  | Grant-Date Fair Value |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Nonvested, December 31, 2021 |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Granted |  |  | 6,250 |  |  | $ | 4.80 |  |  | $ | - |  |  | $ | 29,656 |
Vested |  |  | (6,250 | ) |  | $ | 4.80 |  |  | $ | - |  |  | $ | (29,656 | )
Forfeited |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Nonvested, September 30, 2022 |  |  | - |  |  |  |  |  |  | $ | - |  |  | $ | - |

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=CEAD_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=CEAD_DirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |